Literature DB >> 18162010

Recognition and treatment of obsessive-compulsive disorder.

Wayne K Goodman1, R Bruce Lydiard.   

Abstract

Obsessive-compulsive disorder (OCD) is prevalent, chronic, and potentially disabling. It is characterized by recurrent, unwanted, and distressing thoughts (obsessions) and repetitive, irresistible, behaviors (compulsions). Individuals with OCD recognize that the obsessions and compulsions are senseless or excessive yet they are unable to stop these behaviors. Some etiologic theories of OCD suggest a biological origin, including hypotheses involving the serotonergic system, the glutamatergic system, the orbital cortex and the basal ganglia, and streptococcal throat infections in children. Standard treatments for OCD include selective serotonin reuptake inhibitors (SSRIs) and cognitive-behavior therapy. Combining SSRIs with other medications has relatively little empirical support; however, the adjunctive use of antipsychotics has been shown to be effective. Neurosurgery, such as deep brain stimulation, has also been shown to be effective in select patients with debilitating and refractory OCD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162010     DOI: 10.4088/jcp.1207e30

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  Chronic high-frequency stimulation therapy in hemiparkinsonian rhesus monkeys using an implanted human DBS system.

Authors:  Yiqun Cao; Peihao Yin; Xiaowu Hu; Yiqin Ge; Xiaoping Zhou
Journal:  Neurol Sci       Date:  2012-05-24       Impact factor: 3.307

2.  Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors.

Authors:  Eric Burguière; Patrícia Monteiro; Guoping Feng; Ann M Graybiel
Journal:  Science       Date:  2013-06-07       Impact factor: 47.728

3.  Neuroscience. Illuminating the neural circuitry of compulsive behaviors.

Authors:  Scott L Rauch; William A Carlezon
Journal:  Science       Date:  2013-06-07       Impact factor: 47.728

4.  Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.

Authors:  Alexander Häge; Tobias Banaschewski; Jan K Buitelaar; Rick M Dijkhuizen; Barbara Franke; David J Lythgoe; Konstantin Mechler; Steven C R Williams; Ralf W Dittmann
Journal:  Trials       Date:  2016-03-17       Impact factor: 2.279

5.  The Stuck Song Syndrome: A Case of Musical Obsessions.

Authors:  Juan Manuel Orjuela Rojas; Ingrid Lizeth Lizarazo Rodríguez
Journal:  Am J Case Rep       Date:  2018-11-07

Review 6.  A Systematic Review of Scientific Studies and Case Reports on Music and Obsessive-Compulsive Disorder.

Authors:  Thanh Phuong Anh Truong; Briana Applewhite; Annie Heiderscheit; Hubertus Himmerich
Journal:  Int J Environ Res Public Health       Date:  2021-11-10       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.